Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04745624
Other study ID # 2000028947
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 20, 2020
Est. completion date December 1, 2021

Study information

Verified date February 2022
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic medical record information will be abstracted to collect this information.


Description:

The overall objective of the study will be to examine the safety and efficacy of the VASCADE closure device compared to manual compression (standard of care) to achieve hemostasis after endovascular procedures requiring access within a severely diseased CFA. This study will be a retrospective single center review of 200 patients undergoing endovascular procedures utilizing vascular access within a severely diseased CFA between 2018 and 2020 at Yale New Haven Hospital. A random selection of patients undergoing hemostasis with manual compression (n = 100) and VASCADE vascular closure system (n = 100) will be conducted. The two groups will then be statistically compared with respect to 48-hour and 30-day safety and efficacy outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date December 1, 2021
Est. primary completion date December 1, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: 1. 5, 6 or 7 Fr access within the CFA 2. ACT < 300 seconds 3. Age 18 - 90 years old 4. Severe common femoral arterial disease Percent stenosis > 50, which will be core-lab adjudicated Exclusion Criteria: 1. Ipsilateral CFA access within 30 days preceding or subsequent to the index case 2. Prior ipsilateral closure device use, other than VASCADE 3. High bleeding risk ACT > 300 or > 250 with IIb/IIIa inhibitor Plt < 50K INR > 1.7 on the day of procedure Inherent coagulopathy NOAC, warfarin, or lovenox administered within 24 hours of the procedure 4. Suspected intraluminal thrombus, dissection, pseudoaneurysm, hematoma, or AV Fistula

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Yale University New Haven Connecticut

Sponsors (1)

Lead Sponsor Collaborator
Yale University

Country where clinical trial is conducted

United States, 

References & Publications (3)

Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007 Apr;153(4):606-11. — View Citation

Bangalore S, Bhatt DL. Femoral arterial access and closure. Circulation. 2011 Aug 2;124(5):e147-56. doi: 10.1161/CIRCULATIONAHA.111.032235. — View Citation

Noori VJ, Eldrup-Jørgensen J. A systematic review of vascular closure devices for femoral artery puncture sites. J Vasc Surg. 2018 Sep;68(3):887-899. doi: 10.1016/j.jvs.2018.05.019. Epub 2018 Jun 29. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Adequate hemostasis - (efficacy) No evidence of bleeding after device use within an hour immediately after procedure
Primary No complications after procedure - (safety) Early complications rates: bleeding, thrombosis, pseudoaneurysm, arterio-venous fistula, access site infection, mortality early (48 hours)
Primary No complications after procedure - (safety) Late complications rates: bleeding, thrombosis, pseudoaneurysm, arterio-venous fistula, access site infection, mortality late (30-day)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04299906 - SOLARIS Peripheral PMCF Trial N/A
Recruiting NCT05821829 - Endovascular Treatment of Primary Common FEmoral Artery atheroSclerotic Disease wiTh IntraVAscular Litothripsy
Not yet recruiting NCT04545281 - Physician-Initiated PMCF Trial Investigating the Solaris Vascular Stent Graft for the Treatment of Iliac Lesions Phase 4